(Q37131376)

18 August 2017

Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial (English)

1 reference

multicenter clinical trial

18 August 2017

0 references

0 references

frontotemporal lobar degeneration

1 reference

4

Murray Grossman

1 reference

18 August 2017

22

Bruce L Miller

1 reference

18 August 2017

1

Adam L Boxer

1 reference

18 August 2017

2

David S Knopman

1 reference

18 August 2017

21

M Marsel Mesulam

1 reference

18 August 2017

Daniel I Kaufer

3

1 reference

18 August 2017

Chiadi Onyike

5

1 reference

18 August 2017

Neill Graf-Radford

6

1 reference

18 August 2017

Mario Mendez

7

1 reference

18 August 2017

Diana Kerwin

8

1 reference

18 August 2017

Alan Lerner

9

1 reference

18 August 2017

Chuang-Kuo Wu

10

1 reference

18 August 2017

Mary Koestler

11

1 reference

18 August 2017

Jill Shapira

12

1 reference

18 August 2017

Kathryn Sullivan

13

1 reference

18 August 2017

Kristen Klepac

14

1 reference

18 August 2017

Kristine Lipowski

15

1 reference

18 August 2017

Jerin Ullah

16

1 reference

18 August 2017

Scott Fields

17

1 reference

18 August 2017

Joel H Kramer

18

1 reference

18 August 2017

Jennifer Merrilees

19

1 reference

18 August 2017

John Neuhaus

20

1 reference

18 August 2017

2 January 2013

1 reference

18 August 2017

1 reference

18 August 2017

12

1 reference

18 August 2017

2

1 reference

18 August 2017

149-156

1 reference

The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Off-label medication use in frontotemporal dementia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Development of methodology for conducting clinical trials in frontotemporal lobar degeneration

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

NMDA receptors in clinical neurology: excitatory times ahead

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Behavioral features in semantic dementia vs other forms of progressive aphasias

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Pilot trial of memantine in primary progressive aphasia.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Bedside assessment of executive cognitive impairment: the executive interview

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Memantine in behavioral variant frontotemporal dementia: negative results.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Measuring progression in frontotemporal dementia: implications for therapeutic interventions.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Memantine for behavioral disturbances in frontotemporal dementia: a case series

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

The Zarit Burden Interview: a new short version and screening version.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

Measurement of functional activities in older adults in the community.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3756890

10.1016/S1474-4422(12)70320-4

3 September 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

23290598

1 reference